Miglustat Capsule
Product Images NDC 10148-201
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Miglustat (NDC 10148-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cotherix, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (100 mg Capsule Blister Pack Carton)
migLUstat capsules are a medication containing the active ingredient miglustat. Each capsule contains 100mg of miglustat and inactive ingredients such as magnesium stearate, povidone, and sodium starch glycolate. The capsule shells contain ingredients like gelatin and titanium dioxide, and the shells are printed with edible ink consisting of black iron oxide and shellac. The medication is stored between 20°C to 25°C and kept away from children. This drug is manufactured in Switzerland and distributed in the United States by Patriot Pharmaceuticals. The medication comes in blister packs, with each containing 15 capsules, and the recommended dosage is available in the prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.